Moffitt Cancer Center and Reimagine Care are expanding their AI-enabled virtual oncology care partnership following early results that showed strong patient engagement, reduced emergency visits, and high rates of virtual symptom resolution.
The expanded program is designed to provide continuous cancer care support between scheduled appointments through a combination of oncology-trained clinicians and Reimagine Care’s AI assistant, Remi. The system uses conversational interactions to monitor symptoms, guide patients through care pathways, and identify situations that require clinical intervention.
According to the companies, the initial phase of the program generated nearly 7,000 patient interactions across symptom monitoring, proactive check-ins, patient-reported outcomes, and clinical escalations. Reimagine Care reported that 97% of those interactions were resolved independently without requiring escalation to Moffitt providers.
The organizations also reported that 94% of symptom management encounters were resolved virtually, allowing patients to receive support from home without needing in-person care. Only 2.4% of interactions resulted in emergency department referrals.
Healthcare providers have increasingly focused on extending oncology care beyond clinic visits as cancer treatment becomes more complex and patient volumes continue to rise. Unmanaged symptoms between appointments remain a major contributor to emergency department visits and hospitalizations among cancer patients.
The AI-powered model is intended to create a more continuous flow of information between patients and care teams. Remi conducts regular patient check-ins, tracks symptoms, and surfaces clinically relevant insights to oncology specialists in real time, helping teams identify issues earlier and intervene before conditions worsen.
Patient engagement figures from the pilot phase were also notably high. Reimagine Care reported 99% engagement during the first month of enrollment, with participation remaining above 75% through the third month. The company said 63% of patients were still actively engaged after six months, significantly higher than typical retention rates reported across many digital health programs.
Moffitt executives said the model allows oncology teams to maintain better visibility into patient needs throughout treatment rather than relying solely on information gathered during scheduled visits. The approach is designed to support earlier interventions and provide more consistent care throughout the cancer journey.
The next phase of the partnership will expand access to the virtual oncology model across additional Moffitt locations, allowing more patients to participate in AI-supported care programs. Reimagine Care said the broader rollout will continue using AI-assisted workflows to help manage growing demand for oncology services while reducing pressure on clinical teams.
The expansion reflects a larger trend across healthcare, where organizations are increasingly exploring AI-powered systems to support patient monitoring, care coordination, and clinical decision-making. Oncology has emerged as one of the most active areas for AI deployment due to the complexity of treatment plans and the need for continuous patient support.
Moffitt Cancer has partnered with Reimagine Care to expand an AI-powered virtual oncology program designed to enhance cancer care beyond traditional clinical settings. The collaboration enables Moffitt Cancer to provide continuous patient support, remote monitoring, and personalized care through innovative digital health solutions.
As healthcare organizations increasingly adopt virtual care technologies, Moffitt Cancer continues to lead efforts to improve access, efficiency, and outcomes for oncology patients.
Moffitt Cancer Advances Virtual Oncology Care
The expanded program allows Moffitt Cancer to extend care beyond hospital visits by utilizing artificial intelligence and remote patient monitoring tools. Through this initiative, Moffitt Cancer can identify patient concerns earlier, support treatment adherence, and respond proactively to potential complications.
The virtual oncology model helps ensure that patients remain connected to their care teams throughout their cancer treatment journey, regardless of location.
